Legislation related to obesity treatments; Advocacy for antiobesity medications.
2026 · 1st Quarter (Jan 1 - Mar 31)
NOVO NORDISK, INC.
Filed by HOLLAND & KNIGHT LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 10, 2026
- Income
- $60,000.00
- Expenses
- Not reported
- Registrant
- HOLLAND & KNIGHT LLP
- Client
- NOVO NORDISK, INC.
- Filing UUID
- 91511c4c-a0ce-475b-be48-bba5a5ce5d80
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Legislation related to obesity treatments; Advocacy for antiobesity medications.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.